| Literature DB >> 30803984 |
Amani Sampson1, Laura L Kimberly2,3, Kara N Goldman1, David L Keefe1, Gwendolyn P Quinn1,3.
Abstract
Uterus transplantation is an emerging technology adding to the arsenal of treatments for infertility; specifically the only available treatment for uterine factor infertility. Ethical investigations concerning risks to uteri donors and transplant recipients have been discussed in the literature. However, missing from the discourse is the potential of uterus transplantation in other groups of genetically XY women who experience uterine factor infertility. There have been philosophical inquiries concerning uterus transplantation in genetically XY women, which includes transgender women and women with complete androgen insufficiency syndrome. We discuss the potential medical steps necessary and associated risks for uterus transplantation in genetically XY women. Presently, the medical technology does not exist to make uterus transplantation a safe and effective option for genetically XY women, however this group should not be summarily excluded from participation in trials. Laboratory research is needed to better understand and reduce medical risk and widen the field to all women who face uterine factor infertility. © Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.Entities:
Keywords: ethics; obstetrics and gynaecology; reproductive medicine; sexuality/gender; transplantation
Year: 2019 PMID: 30803984 DOI: 10.1136/medethics-2018-105222
Source DB: PubMed Journal: J Med Ethics ISSN: 0306-6800 Impact factor: 2.903